MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1
about
SSRP1 Contributes to the Malignancy of Hepatocellular Carcinoma and Is Negatively Regulated by miR-497MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes.MicroRNA-497 regulates cisplatin chemosensitivity of cervical cancer by targeting transketolaseMiR-490-3p sensitizes ovarian cancer cells to cisplatin by directly targeting ABCC2.miRNAs and ovarian cancer: a miRiad of mechanisms to induce cisplatin drug resistance.Demethoxycurcumin inhibited human epithelia ovarian cancer cells' growth via up-regulating miR-551a.Association of ribosomal protein S6 kinase 1 with cellular radiosensitivity of non-small lung cancer.miR-497 inhibits epithelial mesenchymal transition in breast carcinoma by targeting Slug.MicroRNAs in gynecological cancers: Small molecules with big implications.MicroRNA-mediated drug resistance in ovarian cancer.Updates and current challenges in microRNA research for personalized medicine in ovarian cancer.Co-targeting of IGF1R/mTOR pathway by miR-497 and miR-99a impairs hepatocellular carcinoma developmentmiR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression.Up-regulation of miR-497 confers resistance to temozolomide in human glioma cells by targeting mTOR/Bcl-2.miR-497 expression, function and clinical application in cancer.Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1.Molecular mechanisms of drug resistance in ovarian cancer.The Roles of microRNAs in Regulating the Expression of PD-1/PD-L1 Immune Checkpoint.Cardamonin enhances the anti-proliferative effect of cisplatin on ovarian cancer.MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1.MicroRNA‑497 inhibits cellular proliferation, migration and invasion of papillary thyroid cancer by directly targeting AKT3.PIM Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian Cancer.lncRNAs are novel biomarkers for differentiating between cisplatin-resistant and cisplatin-sensitive ovarian cancer.Identification of micro-RNA expression profile related to recurrence in women with ESMO low-risk endometrial cancer.Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular DiseasesmiR-497 inhibited proliferation, migration and invasion of thyroid papillary carcinoma cells by negatively regulating YAP1 expressionSLC6A1-miR133a-CDX2 loop regulates SK-OV-3 ovarian cancer cell proliferation, migration and invasion
P2860
Q36939787-699EECD8-29B8-4D91-B5F4-24730EE720EEQ36962575-49DBD292-2CC9-4659-88C0-3D9008F35E1CQ37447951-EBFFCA6B-D198-494A-8E71-69495BEE0FCFQ37732994-607CD470-64EF-4F82-A663-1AE68E3F9E5CQ38633144-92187C45-24CC-4DDD-A8C9-57B8FFDA0154Q38710398-DD475446-FF9B-4DCC-9645-800307483CA1Q38712997-808F2C1E-DA14-4342-AFDF-77AC85355E77Q38809329-1DEAC886-CFB8-4DD4-9B26-B2E08B080D75Q39333266-E48240F0-7E14-4824-88B4-5637C3ABF33FQ39382756-364B8268-591C-4CA6-9F66-4544DFE64292Q39391417-B4EF9A9E-D78D-498C-BC9A-3318017C915DQ41471395-9F31CFA5-1C8E-4564-8FDB-74AB29959FCFQ41520257-E2160995-4BA9-4556-941E-3CA25458C31CQ41995095-EC02D7F4-81C7-4CC5-A9D3-2CCE5876D113Q42317497-16DEC83E-E4ED-47C3-9B29-E38497A1B83EQ44409387-1AFC063F-0BFA-4414-8EC9-DCD32B079433Q48274587-76E44F55-3B9E-424A-AD45-E54C55E58A60Q49164136-A18CA0E5-7ADC-4E05-B1AB-37AD516167E9Q49874776-8CC0E8EF-576F-4A59-84B1-2F6F316D8B40Q52679638-7E6D4294-9A9D-4302-B064-D2B48390CF95Q53093295-BC164D8E-0721-4F6E-9449-60561CDB1699Q54984581-BA165682-2BE2-4A46-8FC9-3496B91E4E56Q55020843-26B8EED5-F6BD-41B7-B917-02183BB664D9Q55278788-DB11DAA1-23BF-48A8-AF8A-2B3291777394Q57300947-21AD1882-F3E6-422D-B1EB-97693B7DD9B1Q58790313-C5C6F414-F114-4A97-8E44-D8A4B0385AB6Q58796642-E456873F-C427-4D96-BDC9-8145805F0E06
P2860
MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1
@ast
MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1
@en
type
label
MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1
@ast
MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1
@en
prefLabel
MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1
@ast
MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1
@en
P2093
P2860
P356
P1433
P1476
MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1
@en
P2093
Fanfei Kong
Guang-Bo Fu
Jun OuYang
Shaohua Xu
Xiaoping Wan
P2860
P304
26457-26471
P356
10.18632/ONCOTARGET.4762
P407
P577
2015-07-03T00:00:00Z